Last update 23 Jun 2026

Changzhou Hansoh Pharmaceutical Co., Ltd.

Subsidiary Company|2018|Jiangsu Sheng, China

Overview

Tags

Neoplasms
Urogenital Diseases
Digestive System Disorders
Small molecule drug
Antibody drug conjugate (ADC)
Bispecific antibody

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Neoplasms18
Nervous System Diseases6
Immune System Diseases6
Endocrinology and Metabolic Disease5
Infectious Diseases4
Hemic and Lymphatic Diseases2
Top 5 Drug TypeCount
Antibody drug conjugate (ADC)7
Small molecule drug6
Biological products2
Bispecific antibody2
Monoclonal antibody2
Top 5 TargetCount
EGFR x c-Met2
TYK2(Tyrosine-protein kinase 2)1
B7-H4 x Top I1
ROR1(Inactive tyrosine-protein kinase transmembrane receptor ROR1)1
CDH6(cadherin 6)1

Related

22
Drugs associated with Changzhou Hansoh Pharmaceutical Co., Ltd.
Inebilizumab-cdon
Target
CD19
Mechanism
CD19 inhibitors [+1]
Active Org.
Amgen, Inc.Amgen, Inc. [+9]
Originator Org.
Duke UniversityDuke University
Active Indication
Myasthenia Gravis [+6]
Inactive Indication
Aggressive B-Cell Non-Hodgkin Lymphoma [+12]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
United States
First Approval Date11 Jun 2020
HS-10374
Target
TYK2
Mechanism
TYK2 inhibitors
Active Org.
Shanghai Hansoh Biomedical Co. Ltd.Shanghai Hansoh Biomedical Co. Ltd. [+2]
Originator Org.
Changzhou Hansoh Pharmaceutical Co., Ltd.
Active Indication
Plaque psoriasis [+3]
Inactive Indication-
Drug Highest PhasePhase 3
First Approval Ctry. / Loc.-
First Approval Date-
Mocertatug Rezetecan
Target
B7-H4 x Top I
Mechanism
B7-H4 inhibitors [+1]
Active Org.
Shanghai Hansoh Biomedical Co. Ltd.Shanghai Hansoh Biomedical Co. Ltd. [+3]
Originator Org.
Shanghai Hansoh Biomedical Co. Ltd.Shanghai Hansoh Biomedical Co. Ltd.
Active Indication
Platinum-Resistant Ovarian Carcinoma [+7]
Inactive Indication-
Drug Highest PhasePhase 3
First Approval Ctry. / Loc.-
First Approval Date-
21
Clinical Trials associated with Changzhou Hansoh Pharmaceutical Co., Ltd.
CTR20255088
/ CompletedPhase 1
利福平胶囊对HS-10374片药代动力学影响的研究
[Translation] Study on the effect of rifampicin capsules on the pharmacokinetics of HS-10374 tablets
CTR20254166
/ RecruitingPhase 1
HS-20117-2注射液在晚期实体瘤患者中的药代动力学、安全性和耐受性的I期临床试验
[Translation] Phase I clinical trial of HS-20117-2 injection in patients with advanced solid tumors to investigate its pharmacokinetics, safety, and tolerability
CTR20253109
/ CompletedPhase 1
HS-10374在肝功能不全及肝功能正常参与者中的药代动力学研究
[Translation] Pharmacokinetic study of HS-10374 in participants with hepatic impairment and normal hepatic function
100 Clinical Results associated with Changzhou Hansoh Pharmaceutical Co., Ltd.
Login to view more data
0 Patents (Medical) associated with Changzhou Hansoh Pharmaceutical Co., Ltd.
Login to view more data
100 Deals associated with Changzhou Hansoh Pharmaceutical Co., Ltd.
Login to view more data
100 Translational Medicine associated with Changzhou Hansoh Pharmaceutical Co., Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 01 Jul 2026

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Discovery
8
2
Preclinical
Phase 1
6
2
Phase 2
Phase 3
3
1
NDA/BLA
Other
3
Login to view more data

Current Projects

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free